Arvinas, Inc. (ARVN) Financials

ARVN Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 647.5 million 260.7 million
Dec. 31, 2025 717.9 million 284.1 million
Sept. 30, 2025 844.3 million 279.9 million
June 30, 2025 909.3 million 300.0 million

ARVN Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -70.5 million 12.1 million
Dec. 31, 2025 -30.6 million 8.5 million
Sept. 30, 2025 -59.2 million 10.2 million
June 30, 2025 -96.6 million 10.3 million

ARVN Net Income

No data available :(

ARVN Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 614.9 million 300000 6.3 million
Dec. 31, 2025 685.4 million 400000 8.5 million
Sept. 30, 2025 787.6 million 400000 7.2 million
June 30, 2025 861.2 million 500000 9.4 million

ARVN Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 64.0 million
Dec. 31, 2025 64.9 million
Sept. 30, 2025 72.9 million
June 30, 2025 73.0 million

ARVN Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 1.3 million 60.0 million 17.2 million -1.9 million
Dec. 31, 2025 200000 61.1 million 22.4 million -
Sept. 30, 2025 100000 64.7 million 21.6 million -
June 30, 2025 1.2 million 68.6 million 25.3 million -

ARVN Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 15.6 million 1.1 million
Dec. 31, 2025 9.5 million 1.2 million
Sept. 30, 2025 41.9 million -
June 30, 2025 22.4 million -

ARVN Revenue by Segment
Graph available only for paid members. Upgrade to see it.

ARVN

Price: $7.38

52 week price:
6.06
14.51

Earnings Per Share: -3.18 USD

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 476209

Market Capitalization: 496.8 million

Links: